Dupilumab Treatment Reduces Signs in Patients with Atopic Hand and Foot Dermatitis: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial

Need to claim your poster? Find the KiKo table at the conference and they'll help you get set up.